Literature DB >> 12565921

Myxovirescin analogues via macrocyclic ring-closing metathesis.

Stéphane Content1, Christopher J Dutton, Lee Roberts.   

Abstract

A short, efficient route has been developed to analogues of myxovirescin using ring-closing metathesis whereby the antibacterial activity has been retained.

Mesh：

Substances：

Year:  2003        PMID： 12565921     DOI： 10.1016/s0960-894x(02)01024-7

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN： 0960-894X            Impact factor:   2.823


  2 in total

1.  Genetic redundancy, proximity, and functionality of lspA, the target of antibiotic TA, in the Myxococcus xanthus producer strain.

Authors:  Yao Xiao; Daniel Wall
Journal:  J Bacteriol       Date:  2014-01-03       Impact factor: 3.490

2.  Myxobacterium-produced antibiotic TA (myxovirescin) inhibits type II signal peptidase.

Authors:  Yao Xiao; Klaus Gerth; Rolf Müller; Daniel Wall
Journal:  Antimicrob Agents Chemother       Date:  2012-01-09       Impact factor: 5.191
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.